NCT00264212View on ClinicalTrials.gov

AMISH : Aprovel for Management of Isolated Systolic Hypertension

PHASE4CompletedINTERVENTIONAL

Enrollment

436

Participants

Timeline

Start Date

August 31, 2004

Conditions

Hypertension

Interventions

DRUG

irbesartan and irbesartan-hydrochlorothiazide

Trial Locations (8)

Unknown

Sanofi-Aventis, Santiago

Sanofi-Aventis, Shanghai

Sanofi-Aventis, Jakarta

Sanofi-Aventis, México

Sanofi-Aventis, Manila

Sanofi-Aventis, Seoul

Sanofi-Aventis, Taipei

Sanofi-Aventis, Bangkok

Sponsors

Lead Sponsor

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Sanofi

INDUSTRY

NCT00264212 - AMISH : Aprovel for Management of Isolated Systolic Hypertension | Biotech Hunter | Biotech Hunter